Grove City, PANCT02844751Now EnrollingIRB Ready

Osteoarthritis Clinical Trial in Grove City, PA

Access cutting-edge osteoarthritis treatment through this phase 2 clinical trial at a research site in Grove City. Study-provided care at no cost to qualified participants.

Sponsored by VivaTech International, Inc.

Quick Self-Assessment

See if you qualify for this Grove City location

Preparing your pre-screening questions…

Expert Care in Grove City

Access osteoarthritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related osteoarthritis treatment provided free

Apply for This Grove City Location

Check if you qualify for this osteoarthritis clinical trial in Grove City, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Grove City

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Grove City site if eligible
  4. 4Begin participation

About This Osteoarthritis Study in Grove City

This is a prospective open-label clinical study of 50 patients to determine safety and treatment potential of autologous cell therapy for pain and inflammation associated with Osteoarthritis of the knee. Follow-up will consist of a larger sample including 4,000 patients.

Sponsor: VivaTech International, Inc.

Who Can Participate

Inclusion Criteria

Patients with indication of Osteoarthritis, grade 2 or more. Can be from degeneration or chronic injury.
Patients range from 18-90 years of age.
Patients must be able to comply with treatment plan, laboratory tests and periodic interviews.
Patients with adequate renal function, Creatinine ≤ 1.5 mg/dl.
Patients with adequate cardiac and respiratory function.
Patients with adequate blood coagulation activity, PT(INR) \< 1.5, APTT
Patients must have adequate immune system function, with no known immunodeficiency disease.
Greater than 6 months knee pain on the index side (left or right knee).

Exclusion Criteria

Neoplastic cancer within 5 years prior to screening, except for cutaneous basal cell or squamous cell cancer resolved by excision
Presence of clinically significant acute or unstable cardiovascular and cerebrovascular (stroke).
Diagnosis of a transient ischemic attack in the 6 months prior to screening.
Patients infected with hepatitis B, C or HIV.
Patients with Body Mass Index (BMI) \> 40kg/m2
Presence of active infection.
Any other illness, psychiatric disorder, alcohol or chemical dependence that in the opinion of the investigator would render a patient unsuitable to participate in the study.
Conditions/therapies/factors which could confound or interfere with the evaluation of pain/mobility including, but not limited to:
Knee instability.
A varus/valgus deformity of more than 10o, a deformity requiring osteotomy or complex surgery.
Gout or pseudo gout
Treatments with strong opioid drugs in the previous 4 weeks for other pain rather than knee osteoarthritis
Corticosteroid injection at treatment site within 1 month
Consistent use of NSAIDs within 48 hours of procedure.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Grove City?

Yes, this clinical trial (NCT02844751) has an active research site in Grove City, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Osteoarthritis Treatment Options in Grove City, PA

If you're searching for osteoarthritis treatment options in Grove City, PA, this clinical trial (NCT02844751) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Grove City research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced osteoarthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all osteoarthritis clinical trials near you to find additional studies recruiting in your area.

More Osteoarthritis Trials in Grove City, PA

See all osteoarthritis clinical trials recruiting in Grove City — not just this study.

Browse Osteoarthritis Trials in Grove City →

Browse More Trials by Condition

Osteoarthritis TrialsAll Conditions →

Ready to Join in Grove City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Grove City, PA